Is there a generic for Methohexital sodium?

Yes. The FDA Orange Book lists 1 approved generic (ANDA) application for Methohexital sodium, referencing the brand BREVITAL SODIUM. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Methohexital sodium?

BREVITAL SODIUM (NDA 011559, PH HEALTH) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Methohexital sodium are approved?

Methohexital sodium is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Methohexital sodium

Methohexital sodium is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:BREVITAL SODIUM · NDA 011559

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
BREVITAL SODIUMRLD×4	PH HEALTH	NDA 011559	—	Approved Prior to Jan 1, 1982

Generic (ANDA) products (1)

Product	Applicant	Application	TE	Approved
METHOHEXITAL SODIUM	ONESOURCE SPECIALTY	ANDA 215488	AP	Oct 03, 2024

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Methohexital sodium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo